Emerging opportunities for the treatment of inflammatory bowel disease

被引：0
|
作者：
Gale, JD [1 ]
McClure, KF
Pullen, N
机构：
[1] Pfizer Ltd, Global Res & Dev, Sandwich CT13 9NJ, Kent, England
[2] Pfizer Inc, Global Res & Dev, Groton, CT 06340 USA
来源：
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 38 | 2003年 / 38卷
关键词：
D O I：
10.1016/S0065-7743(03)38016-9
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：141 / 152
页数：12
相关论文
共 50 条
  • [1] Emerging drugs for the treatment of inflammatory bowel disease
    Wong, Uni
    Cross, Raymond K.
    EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (04) : 369 - 377
  • [2] Emerging Natural Therapies for the Treatment of Inflammatory Bowel Disease
    Joshi, Monika
    Pandey, Manju
    Shankar, Ravi
    Ved, Akash
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024,
  • [3] Current and emerging drugs for the treatment of inflammatory bowel disease
    Triantafillidis, John K.
    Merikas, Emmanuel
    Georgopoulos, Filippos
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2011, 5 : 185 - 210
  • [4] Emerging perspectives on the pathophysiology and treatment of inflammatory bowel disease - Preface
    Irvine, EJ
    Robinson, M
    Miner, PB
    Sartor, RB
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1997, 92 (12): : R1 - R1
  • [5] Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies
    Bretto, Elisabetta
    Ribaldone, Davide Giuseppe
    Caviglia, Gian Paolo
    Saracco, Giorgio Maria
    Bugianesi, Elisabetta
    Frara, Simone
    BIOMEDICINES, 2023, 11 (08)
  • [6] Emerging Nanotechnologies and Microbiome Engineering for the Treatment of Inflammatory Bowel Disease
    Abed, Omar A.
    Attlassy, Younes
    Xu, Jin
    Han, Kai
    Moon, James J.
    MOLECULAR PHARMACEUTICS, 2022, 19 (12) : 4393 - 4410
  • [7] Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies
    Peng Liu
    Caifang Gao
    Hongguo Chen
    Chi Teng Vong
    Xu Wu
    Xudong Tang
    Shengpeng Wang
    Yitao Wang
    Acta Pharmaceutica Sinica B, 2021, 11 (09) : 2798 - 2818
  • [8] Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies
    Liu, Peng
    Gao, Caifang
    Chen, Hongguo
    Vong, Chi Teng
    Wu, Xu
    Tang, Xudong
    Wang, Shengpeng
    Wang, Yitao
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (09) : 2798 - 2818
  • [9] Phosphodiesterase inhibitors and inflammatory bowel disease: emerging therapies in inflammatory bowel disease
    Keshavarzian, Ali
    Mutlu, Ece
    Guzman, Juan P.
    Forsyth, Christopher
    Banan, Ali
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (09) : 1489 - 1506
  • [10] Emerging treatments for inflammatory bowel disease
    Hazel, Karl
    O'Connor, Anthony
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2020, 11
12345